ホーム > 業績 > 2026年度業績

2026年度 業績

英語原著論文

Design and initial evaluation of a certified committee model for review of in vivo gene therapy and related technologies, together with ex vivo gene therapy, under the act on the safety of regenerative medicine.
Hisako Katano, Kenji Konomi, Masaya Nakamura, Ichiro Sekiya.
Regenerative Therapy 1 June 2026, 101131.
https://doi.org/10.1016/j.reth.2026.101131

Association between the cartilage area ratio derived from 3D MRI and patient-reported symptoms in medial knee osteoarthritis.
Yusuke Aimono, Nobutake Ozeki, Hisako Katano, Takuya Takakuwa, Hideyuki Koga, Makoto Tomita, Ichiro Sekiya.
Journal of Orthopaedic Surgery and Research 01 June 2026
https://doi.org/10.1186/s13018-026-06986-y